Bausch Health Companies Stock Today

BHC Stock  CAD 11.45  0.03  0.26%   

Performance

15 of 100

 
Weak
 
Strong
Good

Odds Of Distress

Less than 33

 
High
 
Low
Below Average
Bausch Health is selling at 11.45 as of the 22nd of November 2024; that is 0.26 percent decrease since the beginning of the trading day. The stock's open price was 11.48. Bausch Health has about a 33 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. Equity ratings for Bausch Health Companies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of May 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Bausch Health Companies Inc. The company has 367.8 M outstanding shares of which 3.37 M shares are currently shorted by private and institutional investors with about 15.17 days to cover all short positions. More on Bausch Health Companies

Moving together with Bausch Stock

  0.63TPX-B Molson Coors CanadaPairCorr
  0.83FFH Fairfax FinancialPairCorr

Bausch Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bausch Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bausch Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Bausch Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bausch Health's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
PresidentThomas Appio
Thematic IdeaHealth Management (View all Themes)
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Management, Health Care, Pharmaceuticals, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal Testing
Bausch Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Bausch Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Bausch Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Bausch Health's financial leverage. It provides some insight into what part of Bausch Health's total assets is financed by creditors.
Liquidity
Bausch Health cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Bausch Health Companies has accumulated 22.39 B in total debt with debt to equity ratio (D/E) of 906.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Bausch Health Companies has a current ratio of 1.19, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Bausch Health until it has trouble settling it off, either with new capital or with free cash flow. So, Bausch Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bausch Health Companies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bausch to invest in growth at high rates of return. When we think about Bausch Health's use of debt, we should always consider it together with cash and equity.

Other Cashflows From Financing Activities

2.51 Billion
Bausch Health Companies (BHC) is traded on Toronto Exchange in Canada and employs 20,270 people. Bausch Health is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bausch Health's market, we take the total number of its shares issued and multiply it by Bausch Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bausch Health Companies operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 367.8 M outstanding shares of which 3.37 M shares are currently shorted by private and institutional investors with about 15.17 days to cover all short positions. Bausch Health Companies has accumulated about 564 M in cash with 1.03 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.49.
Check Bausch Health Probability Of Bankruptcy
Ownership Allocation
Bausch Health holds a total of 367.8 Million outstanding shares. The majority of Bausch Health Companies outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Bausch Health Companies to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Bausch Health. Please pay attention to any change in the institutional holdings of Bausch Health Companies as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bausch Ownership Details

Bausch Health Companies Risk Profiles

Although Bausch Health's alpha and beta are two of the key measurements used to evaluate Bausch Health's performance over the market, the standard measures of volatility play an important role as well.

Bausch Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bausch Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bond Analysis Now

   

Bond Analysis

Evaluate and analyze corporate bonds as a potential investment for your portfolios.
All  Next Launch Module

Bausch Health Corporate Management

Elected by the shareholders, the Bausch Health's board of directors comprises two types of representatives: Bausch Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bausch. The board's role is to monitor Bausch Health's management team and ensure that shareholders' interests are well served. Bausch Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bausch Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
John BarresiController, VPProfile
Garen SarafianVP RelationsProfile
Jeff HartnessCommercial AccessProfile
Kathleen FitzpatrickExecutive OfficerProfile
Arthur ShannonIR Contact OfficerProfile
Jiny MBASenior MedicalProfile
Tage MDChief RDProfile
When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.